151. Chronic Inflammatory Bowel Disease as Key Manifestation of Atypical ARTEMIS Deficiency.
- Author
-
Rohr, Jan, Pannicke, Ulrich, Döring, Michaela, Schmitt-Graeff, Annette, Wiech, Elisabeth, Busch, Andreas, Speckmann, Carsten, Müller, Ingo, Lang, Peter, Handgretinger, Rupert, Fisch, Paul, Schwarz, Klaus, and Ehl, Stephan
- Subjects
- *
INTESTINAL diseases , *INFLAMMATION , *INFLAMMATORY bowel diseases , *LYMPHOPENIA , *T cells , *STEROIDS - Abstract
We describe a girl presenting at age 6 years with a history of chronic ulcerating intestinal inflammation since 9 months of age. She exhibited a severe, steroid-dependent clinical course of intestinal inflammation over several years in the absence of serious infections. Immunodeficiency was first considered at 6 years of age due to chronic lymphopenia. Immunophenotyping revealed low B and T cell counts with few naïve T cells, a skewed TCR repertoire, and TCR γ/δ T cell predominance, suggesting a defect of lymphocyte development. Genetic and functional analyses identified a hypomorphic mutation in the DCLRE1C (ARTEMIS) gene compromising V(D)J recombination efficiency, but allowing residual T and B cell development. Hematopoetic stem cell transplantation reconstituted the lymphocyte compartment and cured the inflammatory bowel disease. This report illustrates that a genetic disorder of lymphocyte development can present with chronic inflammatory bowel disease as the dominant phenotype in the absence of severe infection susceptibility. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF